General Proximity
Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease
$20MStrategic
Role not disclosedLoading investors…
Activity from announced rounds
Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease